BioHarvest Sciences Inc. BioHarvest Sciences Inc.

BioHarvest Sciences Inc.

BHSC

株式のランク #21531
Based in Vancouver, Canada, BioHarvest Sciences Inc. and its subsidiaries are... Based in Vancouver, Canada, BioHarvest Sciences Inc. and its subsidiaries are active globally, including in Israel, providing nutraceutical products derived from super fruits and cannabis. The company employs a proprietary plant cell growth technology that effectively produces desired active secondary metabolites without needing to cultivate the entire plant. BioHarvest is responsible for the design, development, production, and commercialization of Vinia, a red grape powder nutraceutical, alongside its medical cannabis offerings.
株価
$5.83
最終同期: 2025-02-14
時価総額
$101.10M
変化(1日)
4.17%
変化(1年)
-5.89%
国
CA
取引 BioHarvest Sciences Inc. (BHSC)

カテゴリー

Healthcare
BioHarvest Sciences Inc.(BHSC)の収益
Sep 2024 時点の収益 TTM: $22.43M
BioHarvest Sciences Inc. の最新の財務報告によると、現在の収益 (TTM) は $22.43M です。2022 年には $5.50M の収益があり、これは 2021 年の $2.10M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
BioHarvest Sciences Inc. の収益履歴(2014 ~ 2026)
各年末の収益
年 収益 変化
2026 (TTM) $22.43M 77.00%
2023 $12.67M 130.48%
2022 $5.50M 161.56%
2021 $2.10M 430.81%
2020 $396.00K 81.65%
2019 $218.00K -51.45%
2018 $449.00K 1,022.50%
2017 $40.00K 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%